APOE and immunity: Research highlights – ADSP

Title: APOE and immunity: Research highlights

Author(s): Kloske, CM; Barnum, CJ; Batista, AF; Bradshaw, EM; Brickman, AM; Bu, G; Dennison, J; Gearon, MD; Goate, AM; Haass, C; Heneka, MT; Hu, WT; Huggins, LKL; Jones, NS; Koldamova, R; Lemere, CA; Liddelow, SA; Marcora, E; Marsh, SE; Nielsen, HM; Petersen, KK; Petersen, M; Piña-Escudero, SD; Qiu, WQ; Quiroz, YT; Reiman, E; Sexton, C; Tansey, MG; Tcw, J; Teunissen, CE; Tijms, BM; van der Kant, R; Wallings, R; Weninger, SC; Wharton, W; Wilcock, DM; Wishard, TJ; Worley, SL; Zetterberg, H; Carrillo, MC;

Year: 2023;

Journal: Alzheimer's & Dementia: The Journal of the Alzheimer's Association;

Volume: 19;

Issue: 6;

DOI: 10.1002/alz.13020

Abstract:

INTRODUCTION: At the Alzheimer’s Association’s APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer’s disease and other dementias.
METHODS: The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.
RESULTS: During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).
DISCUSSION: This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer’s disease as well as related promising directions in drug development.